RxDoctor Payments Data

Mehmood Mehdi, MD

Psychiatry · Loganville, GANPI 1922017987

Payments from drug & device makers

$1,391in general payments, 2019–2025

Across 69 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$388
  • Alkermes, Inc.$166
  • Otsuka America Pharmaceutical, Inc.$146
  • AbbVie$114
  • Johnson & Johnson$100
  • Takeda Pharmaceuticals U.S.A., Inc.$84
  • plus $394 from 14 others

What the payments were for

  • Food & beverage$1,17084%
  • Education$22116%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,391 in reported general payments places this provider in the 70th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$77,937
Medicare patients
137
Services billed
885

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate49$125,967
RexultiBrexpiprazole13$20,695
VraylarCariprazine Hcl11$16,028
Lurasidone Hcl26$7,783
Paliperidone ErPaliperidone42$5,038
AzstarysSerdexmethylphen/Dexmethylphen12$4,828
VyvanseLisdexamfetamine Dimesylate11$4,008
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine59$2,697
Aripiprazole31$2,106
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine100$1,796
Methylphenidate Hcl58$1,415
Divalproex Sodium ErDivalproex Sodium73$1,401
Ziprasidone Hcl11$1,218
Clonazepam136$763
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$728

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$100$125,96749 claims
Otsuka America Pharmaceutical, Inc.Rexulti$146$20,69513 claims
AbbVieVraylar$114$16,02811 claims
Corium, LLCAzstarys$20$4,82812 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$84$4,00811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Loganville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →